Chargement en cours...
Requirements for multi-level systems pharmacology models to reach end-usage: the case of type 2 diabetes
We are currently in the middle of a major shift in biomedical research: unprecedented and rapidly growing amounts of data may be obtained today, from in vitro, in vivo and clinical studies, at molecular, physiological and clinical levels. To make use of these large-scale, multi-level datasets, corre...
Enregistré dans:
| Publié dans: | Interface Focus |
|---|---|
| Auteurs principaux: | , , , , , , , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
The Royal Society
2016
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4759745/ https://ncbi.nlm.nih.gov/pubmed/27051506 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1098/rsfs.2015.0075 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|